172 related articles for article (PubMed ID: 26495926)
1. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers.
Prasad GL; Jones BA; Chen P; Gregg EO
Clin Chem Lab Med; 2016 Apr; 54(4):633-42. PubMed ID: 26495926
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles associated with cigarette smoking and moist snuff consumption.
Arimilli S; Madahian B; Chen P; Marano K; Prasad GL
BMC Genomics; 2017 Feb; 18(1):156. PubMed ID: 28193179
[TBL] [Abstract][Full Text] [Related]
3. Differences in biomarkers of inflammation and immune responses in chronic smokers and moist snuff users.
Tran QT; Arimilli S; Scott E; Chen P; Prasad GL
Cytokine; 2021 Jan; 137():155299. PubMed ID: 33011400
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory profile analysis reveals differences in cytokine expression between smokers, moist snuff users, and dual users compared to non-tobacco consumers.
Sgambato JA; Jones BA; Caraway JW; Prasad GL
Cytokine; 2018 Jul; 107():43-51. PubMed ID: 29217402
[TBL] [Abstract][Full Text] [Related]
5. Study of cardiovascular disease biomarkers among tobacco consumers, part 1: biomarkers of exposure.
Campbell LR; Brown BG; Jones BA; Marano KM; Borgerding MF
Inhal Toxicol; 2015 Feb; 27(3):149-56. PubMed ID: 25787703
[TBL] [Abstract][Full Text] [Related]
6. Pathway Analysis of Global Metabolomic Profiles Identified Enrichment of Caffeine, Energy, and Arginine Metabolism in Smokers but Not Moist Snuff Consumers.
Liu G; Lee DP; Schmidt E; Prasad GL
Bioinform Biol Insights; 2019; 13():1177932219882961. PubMed ID: 31666793
[TBL] [Abstract][Full Text] [Related]
7. Study of cardiovascular disease biomarkers among tobacco consumers. Part 3: evaluation and comparison with the US National Health and Nutrition Examination Survey.
Marano KM; Kathman SJ; Jones BA; Nordskog BK; Brown BG; Borgerding MF
Inhal Toxicol; 2015 Feb; 27(3):167-73. PubMed ID: 25787702
[TBL] [Abstract][Full Text] [Related]
8. Global methylation profiles in buccal cells of long-term smokers and moist snuff consumers.
Jessen WJ; Borgerding MF; Prasad GL
Biomarkers; 2018 Nov; 23(7):625-639. PubMed ID: 29771158
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes.
Goniewicz ML; Smith DM; Edwards KC; Blount BC; Caldwell KL; Feng J; Wang L; Christensen C; Ambrose B; Borek N; van Bemmel D; Konkel K; Erives G; Stanton CA; Lambert E; Kimmel HL; Hatsukami D; Hecht SS; Niaura RS; Travers M; Lawrence C; Hyland AJ
JAMA Netw Open; 2018 Dec; 1(8):e185937. PubMed ID: 30646298
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers.
Lowe FJ; Gregg EO; McEwan M
Clin Chem Lab Med; 2009; 47(3):311-20. PubMed ID: 19676143
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of biomarkers of exposure in adult cigarette smokers using Marlboro snus.
Sarkar M; Liu J; Koval T; Wang J; Feng S; Serafin R; Jin Y; Xie Y; Newland K; Roethig HJ
Nicotine Tob Res; 2010 Feb; 12(2):105-16. PubMed ID: 20026503
[TBL] [Abstract][Full Text] [Related]
12. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
Hecht SS; Carmella SG; Murphy SE; Riley WT; Le C; Luo X; Mooney M; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1567-72. PubMed ID: 17684130
[TBL] [Abstract][Full Text] [Related]
13. A study to evaluate the effect on Mouth Level Exposure and biomarkers of exposure estimates of cigarette smoke exposure following a forced switch to a lower ISO tar yield cigarette.
Shepperd CJ; Eldridge AC; Errington G; Dixon M
Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S13-24. PubMed ID: 21672597
[TBL] [Abstract][Full Text] [Related]
14. A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
Murphy SE; Link CA; Jensen J; Le C; Puumala SS; Hecht SS; Carmella SG; Losey L; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1617-23. PubMed ID: 15466978
[TBL] [Abstract][Full Text] [Related]
15. Smokeless tobacco or nicotine replacement therapy has no effect on serum immunoglobulin levels.
Gyllén P; Andersson BA; Qvarfordt I
Respir Med; 2004 Feb; 98(2):108-14. PubMed ID: 14971872
[TBL] [Abstract][Full Text] [Related]
16. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
[TBL] [Abstract][Full Text] [Related]
17. A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product.
Miura N; Yuki D; Minami N; Kakehi A; Futamura Y
Regul Toxicol Pharmacol; 2015 Apr; 71(3):498-506. PubMed ID: 25683775
[TBL] [Abstract][Full Text] [Related]
18. Smokers of menthol and nonmenthol cigarettes exhibit similar levels of biomarkers of smoke exposure.
Heck JD
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):622-9. PubMed ID: 19190153
[TBL] [Abstract][Full Text] [Related]
19. Assessment of mouth-level exposure to tobacco constituents in U.S. snus consumers.
Caraway JW; Chen PX
Nicotine Tob Res; 2013 Mar; 15(3):670-7. PubMed ID: 22990227
[TBL] [Abstract][Full Text] [Related]
20. Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect.
Nordskog BK; Brown BG; Marano KM; Campell LR; Jones BA; Borgerding MF
Inhal Toxicol; 2015 Feb; 27(3):157-66. PubMed ID: 25787701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
